Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Diabetes

Free Subscription 15.09.2025 1 Acta Ophthalmol 1 Am J Nephrol 1 Atherosclerosis 1 Biochem Biophys Res Commun 3 BMJ 3 Diabet Med 2 Diabetes 3 Diabetes Care 15 Diabetes Obes Metab 8 Diabetologia 1 Invest Ophthalmol Vis Sci 2 J Am Coll Cardiol 1 J Clin Endocrinol Metab 1 J Clin Invest 4 J Diabetes Complications 8 PLoS One 1 Retina 1 Transplant Proc

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Ophthalmol

1. POSCHKAMP B, Kantz L, Augstein P, Tayar A, et al
   Customizing AI-based screening with real-world data: Practical insights from diabetic retinopathy.
   Acta Ophthalmol. 2025 Sep 11. doi: 10.1111/aos.17591.
   PubMed         Abstract available
   
   

   
   Am J Nephrol

2. FERNANDEZ-FERNANDEZ B, Hasegawa T, Saruta Y, Li Guan Y, et al
   Plasma IL-22 predicts progression of early diabetic kidney disease.
   Am J Nephrol. 2025 Sep 8:1-21. doi: 10.1159/000547738.
   PubMed         Abstract available
   
   

   
   Atherosclerosis

3. SVENDSEN K, Christensen JJ, Igland J, Krogh HW, et al
   Risk of adverse pregnancy outcomes and impact of statin use in pregnant women with familial hypercholesterolemia.
   Atherosclerosis. 2025;408:120442.
   PubMed         Abstract available
   
   

   
   Biochem Biophys Res Commun

4. ZU J, Wang J, He Z, Zhao J, et al
   Dapagliflozin improves diabetic retinopathy in mice by inhibiting LAMA1 and regulating the PI3K/AKT signaling pathway.
   Biochem Biophys Res Commun. 2025;782:152514.
   PubMed         Abstract available
   
   

   
   BMJ

5. LUCEWICZ SAMARAWICKRAMA A, Pasupathy D
   Preventing gestational diabetes.
   BMJ. 2025;390:r1900.
   PubMed        
   
   
6. SUJAN MJ, Skarstad HM, Rosvold G, Fougner SL, et al
   Time restricted eating and exercise training before and during pregnancy for people with increased risk of gestational diabetes: single centre randomised controlled trial (BEFORE THE BEGINNING).
   BMJ. 2025;390:e083398.
   PubMed         Abstract available
   
   
7. TAYLOR L
   WHO adds controversial cancer and diabetes treatments to essential medicines list.
   BMJ. 2025;390:r1881.
   PubMed        
   
   

   
   Diabet Med

8. LIPSCOMBE LL, Ali FM, Bartlett T, Shah BR, et al
   A multi-pronged research and policy strategy to address the global diabetes epidemic.
   Diabet Med. 2025 Sep 9:e70135. doi: 10.1111/dme.70135.
   PubMed        
   
   
9. HEYMAN E, Peters TM, Lespagnol E, Parent C, et al
   Exploring gender differences in physical activity and related barriers in children and adults living with type 1 diabetes: A narrative review.
   Diabet Med. 2025 Sep 9:e70132. doi: 10.1111/dme.70132.
   PubMed         Abstract available
   
   
10. AMED S, Bone JN, Kishore SB, Zhang Q, et al
    A longitudinal cohort study describing childhood type 1 diabetes incidence and prevalence rates in British Columbia, Canada over 27 years (1997-2023).
    Diabet Med. 2025 Sep 9:e70133. doi: 10.1111/dme.70133.
    PubMed         Abstract available
    
    

    
    Diabetes

11. LI W, Cheng Y, Cui A, Huang M, et al
    Multiomics Integration of Epigenetics, Proteomics, and Metabolomics Identifies Putative Drug Targets and Improves Early Prediction for Diabetes.
    Diabetes. 2025 Sep 12:db250354. doi: 10.2337/db25-0354.
    PubMed         Abstract available
    
    
12. FLAMMER ER, Christopher MW, Powers ER, Broncucia H, et al
    Serum Metabolomics Reveals Potential Differences in Gut Microbiota-Associated Metabolites in Twins Discordant for Type 1 Diabetes.
    Diabetes. 2025 Sep 11:db250156. doi: 10.2337/db25-0156.
    PubMed         Abstract available
    
    

    
    Diabetes Care

13. NASH B, Sher L, James S, Nehme Z, et al
    Reimagining Acute Diabetes Care: Insights From the Victorian Virtual Emergency Department.
    Diabetes Care. 2025 Sep 8:dc250852. doi: 10.2337/dc25-0852.
    PubMed         Abstract available
    
    
14. AYATI A, Azzam S, Ko S, Ben-David C, et al
    Quantifying Barriers to Diabetic Eye Screening: A Two-Center Study at the University of California.
    Diabetes Care. 2025 Sep 9:dc250951. doi: 10.2337/dc25-0951.
    PubMed         Abstract available
    
    
15. RICHARDSON R, Thabit H
    Goodhart's Law in Diabetes Care: The Hidden Drawbacks of Overoptimizing CGM Metrics.
    Diabetes Care. 2025 Sep 9:dc251985. doi: 10.2337/dc25-1985.
    PubMed        
    
    

    
    Diabetes Obes Metab

16. DAVIDSEN L, Jensen MH, Drewes AM, Knop FK, et al
    Declining incidence of hypoglycaemia in diabetes secondary to chronic pancreatitis: A nationwide cohort study from 2003 to 2022.
    Diabetes Obes Metab. 2025 Sep 8. doi: 10.1111/dom.70106.
    PubMed         Abstract available
    
    
17. LI W, Huang L, Wang R, Peng P, et al
    Comparative efficacy and safety of Glucagon-like pepetide-1 receptor agonists with metformin in Asian versus non-Asian patients with type 2 diabetes: A systematic review and meta-analysis.
    Diabetes Obes Metab. 2025 Sep 11. doi: 10.1111/dom.70084.
    PubMed         Abstract available
    
    
18. LEE YT, Wu JY, Chang TW, Hung CH, et al
    Impact of SGLT2 inhibitors on the risk of age-related ocular diseases in patients with type 2 diabetes mellitus: A target trial emulation study.
    Diabetes Obes Metab. 2025 Sep 11. doi: 10.1111/dom.70131.
    PubMed         Abstract available
    
    
19. CHENG X, Fu Z, Chen Y, Wang J, et al
    Semaglutide attenuates diabetic retinopathy progression via ameliorating retinal vasculopathy and oxidative stress in vivo and in vitro.
    Diabetes Obes Metab. 2025 Sep 10. doi: 10.1111/dom.70107.
    PubMed         Abstract available
    
    
20. ZHANG A, Zhichen B, Kidoguchi S, Nishiyama A, et al
    An SGLT2 inhibitor, canagliflozin, reduces blood glucose level in the renal capillaries and protects the capillary network in the diabetic rats.
    Diabetes Obes Metab. 2025 Sep 10. doi: 10.1111/dom.70118.
    PubMed         Abstract available
    
    
21. LIU A, Shao Y, Chen J, Ng CS, et al
    The healthcare and economic burden associated with inadequate risk factor control for type 2 diabetes in Hong Kong: A population-based modelling study.
    Diabetes Obes Metab. 2025 Sep 10. doi: 10.1111/dom.70081.
    PubMed         Abstract available
    
    
22. HASEBE M, Su CY, Keidai Y, Minamino H, et al
    Cardiovascular risk reduction with glucagon-like peptide-1 receptor agonists is proportional to HbA1c lowering in type 2 diabetes: An updated meta-regression analysis incorporating FLOW and SOUL trials.
    Diabetes Obes Metab. 2025 Sep 9. doi: 10.1111/dom.70121.
    PubMed         Abstract available
    
    
23. JOUBERT M, Meyer L, Bekka S, Rakotoarisoa L, et al
    Hypoglycemia incidence and behavioural adjustments during free-living unstructured physical activity in adults with type 1 diabetes using AID systems: Results from the RAPPID study.
    Diabetes Obes Metab. 2025 Sep 9. doi: 10.1111/dom.70122.
    PubMed         Abstract available
    
    
24. GUAN H, Jiang H, Yuan H, Sun J, et al
    Long-term efficacy and safety of tirzepatide in participants with type 2 diabetes with inadequate glycaemic control on metformin and/or sulfonylurea: Post-hoc analysis of SURPASS-4.
    Diabetes Obes Metab. 2025 Sep 9. doi: 10.1111/dom.70047.
    PubMed         Abstract available
    
    
25. SCHIERBAUER J, Sanfilippo S, Wachsmuth N, Moser O, et al
    Association between glycated haemoglobin A(1c) and total haemoglobin mass in adults with type 1 diabetes mellitus. A proof-of-concept study.
    Diabetes Obes Metab. 2025 Sep 8. doi: 10.1111/dom.70007.
    PubMed        
    
    
26. FJAELDSTAD AW, Norman K, Bjerg L
    Subjective smell- and taste loss in diabetes-A questionnaire-based study on 47 011 individuals with diabetes and matched controls.
    Diabetes Obes Metab. 2025 Sep 8. doi: 10.1111/dom.70099.
    PubMed         Abstract available
    
    
27. ZHANG Y, Zhou J, Chen X, Huang H, et al
    Optimal type and dose of exercise to improve glycated haemoglobin in individuals with type 1 diabetes: A systematic review and Bayesian dose-response network meta-analysis of RCTs.
    Diabetes Obes Metab. 2025 Sep 8. doi: 10.1111/dom.70115.
    PubMed         Abstract available
    
    
28. RABBONE I, Tinti D, Rigamonti A, Mossetto C, et al
    Comparable glycemic outcomes with insulin glargine and insulin degludec during exercise in adolescents with type 1 diabetes using a standardized management protocol.
    Diabetes Obes Metab. 2025 Sep 8. doi: 10.1111/dom.70108.
    PubMed        
    
    
29. SHARMA A, Ali Baig S, Thayakaran R, Rengarajan L, et al
    Clinical characteristics and outcomes of diabetes-related ketoacidosis (DKA) in sodium-glucose co-transporter-2 inhibitor (SGLT2i) users with type 2 diabetes.
    Diabetes Obes Metab. 2025 Sep 8. doi: 10.1111/dom.70098.
    PubMed         Abstract available
    
    
30. KANU C, Boye KS, Poon JL, Goetz I, et al
    Appetite, eating attitudes, and eating behaviours during treatment with retatrutide in adults with type 2 diabetes: Results of a phase 2 study.
    Diabetes Obes Metab. 2025 Sep 8. doi: 10.1111/dom.70097.
    PubMed         Abstract available
    
    

    
    Diabetologia

31. DENG Y, Wu H, Ng NYH, Tam CHT, et al
    Association between maternal glucose levels in pregnancy and offspring's metabolism and adiposity: an 18-year birth cohort study.
    Diabetologia. 2025;68:2205-2216.
    PubMed         Abstract available
    
    
32. MARUCCI A, Derhourhi M, Menzaghi C, Fini G, et al
    The role of SLC19A2 variants in the wide spectrum of non-autoimmune abnormalities of glucose homeostasis.
    Diabetologia. 2025;68:2240-2246.
    PubMed         Abstract available
    
    
33. ZHANG RX, Li AQ, Zhao XY, Wang B, et al
    Identification of SEC16B as a novel regulator of glucose homeostasis.
    Diabetologia. 2025;68:2247-2262.
    PubMed         Abstract available
    
    
34. ANDERSEN AK, Lyng KD, Faerch K, Vistisen D, et al
    What are the most important research questions within prediabetes? A priority setting partnership in collaboration with patients, healthcare professionals and researchers.
    Diabetologia. 2025;68:2156-2167.
    PubMed         Abstract available
    
    
35. WHELEHAN G, Hakim O, Ladwa M, Bello O, et al
    Ethnic differences in beta cell function and pancreatic fat in Black African and White European men across a spectrum of glucose tolerance.
    Diabetologia. 2025;68:2290-2295.
    PubMed         Abstract available
    
    
36. SUBRAMANIAN V, Sherman AS, Holst JJ, Knop FK, et al
    Evaluating the role of alpha cell dysregulation in the progression to type 2 diabetes using mathematical simulations.
    Diabetologia. 2025 Sep 9. doi: 10.1007/s00125-025-06524.
    PubMed         Abstract available
    
    
37. CANHA D, Choudhary P, Cosson E, Banu I, et al
    Time below range alone is insufficient to identify severe hypoglycaemia risk in type 1 diabetes-the critical role of hypoglycaemia awareness: results from the SFDT1 study.
    Diabetologia. 2025 Sep 9. doi: 10.1007/s00125-025-06536.
    PubMed         Abstract available
    
    
38. GIORGINO F, Alzaid F, Pantea Stoian A, Chan JCN, et al
    Global challenges in diabetes research and care: which way forward? An appraisal from the EASD Global Council.
    Diabetologia. 2025 Sep 10. doi: 10.1007/s00125-025-06504.
    PubMed         Abstract available
    
    

    
    Invest Ophthalmol Vis Sci

39. HE Y, Zhou J, Wang J, Huang S, et al
    Novel Visceral Obesity Indicators and Associated Metabolic Fingerprint in Incident Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2025;66:17.
    PubMed         Abstract available
    
    

    
    J Am Coll Cardiol

40. BLAIS JE, Yan VKC, Chan EWY, Wong ICK, et al
    Safety and Effectiveness of Statins for Primary Prevention in Adults With Type 1 Diabetes: An Emulation.
    J Am Coll Cardiol. 2025;86:797-809.
    PubMed         Abstract available
    
    
41. KANG D, Choi KH, Kim JH
    Statins in Type 1 Diabetes: Bridging the Evidence Gap With Target Trial Emulation.
    J Am Coll Cardiol. 2025;86:810-812.
    PubMed        
    
    

    
    J Clin Endocrinol Metab

42. MACLEOD SR, Tich JN, Marvald J, Zhang YV, et al
    The Influence of Social Vulnerability and Race on Diabetes Control.
    J Clin Endocrinol Metab. 2025 Sep 6:dgaf502. doi: 10.1210.
    PubMed         Abstract available
    
    

    
    J Clin Invest

43. VIRGILIO E, Tielens S, Bonfield G, Nian FS, et al
    Recessive TMEM167A variants cause neonatal diabetes, microcephaly and epilepsy syndrome.
    J Clin Invest. 2025 Sep 9:e195756. doi: 10.1172/JCI195756.
    PubMed         Abstract available
    
    

    
    J Diabetes Complications

44. KYKKANEN E, Kaartinen I, Arponen O, Vuorlaakso M, et al
    Low imaging-detected muscle mass as a prognostic factor for overall and amputation-free survival in patients undergoing lower extremity amputation.
    J Diabetes Complications. 2025;39:109119.
    PubMed         Abstract available
    
    
45. FRALICK M, Hojbjerg Lassen MC, Rangrej J, Asgari S, et al
    Predicting the occurrence of DKA following sodium glucose co-transporter-2 inhibitors: An international cohort study.
    J Diabetes Complications. 2025;39:109144.
    PubMed         Abstract available
    
    
46. JAMES S, Barber R, Forster J, Sawatsky L, et al
    Atypical complications and co-morbidities of type 1 diabetes in young adults.
    J Diabetes Complications. 2025;39:109158.
    PubMed         Abstract available
    
    
47. JOHNSON TM, Churilla JR
    Trends in mean serum insulin and hyperinsulinemia among US adults without diabetes 1999-2018.
    J Diabetes Complications. 2025;39:109159.
    PubMed         Abstract available
    
    

    
    PLoS One

48. LI Z, Wu M, Wang P, Xie W, et al
    Sedentary behavior mediates the association between weight-adjusted waist index and cardiovascular disease in patients with diabetes.
    PLoS One. 2025;20:e0331173.
    PubMed         Abstract available
    
    
49. LEE Y, Lee SH, Moon E, Park H, et al
    Compartment-specific adaptive responses and dysregulation under NQO1 deficiency in diabetic kidney disease: A transcriptomic GSEA-based investigation.
    PLoS One. 2025;20:e0331582.
    PubMed         Abstract available
    
    
50. SINGH S, Abd Raof AS, Lee-Boey JS, Mohd Zaini HS, et al
    Cohort profile: The Multiethnic Lifestyle, Obesity and Diabetes Registry in Malaysia (MeLODY) retrospective cohort in a middle-income country in Southeast Asia.
    PLoS One. 2025;20:e0331571.
    PubMed         Abstract available
    
    
51. MICHIELSEN M, Bekhuis Y, Claes J, Decorte E, et al
    Exploring the limits of exercise capacity in adults with type II diabetes.
    PLoS One. 2025;20:e0331737.
    PubMed         Abstract available
    
    
52. WANG P, Jiang S, Hua Y, Xie W, et al
    Relationship between the blood urea nitrogen to serum albumin ratio and in-hospital mortality in patients with type 2 diabetes mellitus complicated with ischemic stroke.
    PLoS One. 2025;20:e0330168.
    PubMed         Abstract available
    
    
53. TANG S, Li Y, Li R, Yang H, et al
    Prevalence and patterns of multimorbidity among adults in rural Shanxi Province, China: A post-hoc exploratory subgroup analysis of a cross-sectional study.
    PLoS One. 2025;20:e0330935.
    PubMed         Abstract available
    
    
54. CHEN B, Li Z, Zhao J, Dong H, et al
    Factors associated with aspirin resistance in diabetic patients: A metabolic and inflammatory profile analysis.
    PLoS One. 2025;20:e0332323.
    PubMed         Abstract available
    
    
55. ABURA A, Gao S
    C3AR1 may aggravate diabetic nephropathy by mediating oxidative stress via ITGB2 regulation in renal tubular epithelial cells.
    PLoS One. 2025;20:e0331900.
    PubMed         Abstract available
    
    

    
    Retina

56. LU ES, Lu Y, Cui Y, Zeng R, et al
    Expanded field OCTA Biomarkers Associated with the Development of Tractional Retinal Detachment in Proliferative Diabetic Retinopathy.
    Retina. 2025 Sep 3. doi: 10.1097/IAE.0000000000004661.
    PubMed         Abstract available
    
    

    
    Transplant Proc

57. YANG KH, Ryu JH, Choi BH
    Simultaneous Pancreas and Dual Kidney Transplantation from a Standard Criteria Donor: First Report From Korea.
    Transplant Proc. 2025 Aug 11:S0041-1345(25)00368.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Diabetes is free of charge.